You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨“香港特專科技第一股”晶泰科技首日上市大升24%
格隆匯 06-13 10:23
香港首間以《上市規則》第18C章上市的特專科技新股晶泰科技(2228.HK),今早首日掛牌高開2%後盤中進一步走高,一度拉昇大升24.62%至6.58港元,截至目前成交超2.7億港元。晶泰科技以每股5.28港元定價,集資淨額10.43億港元。公開發售獲超額認購102.35倍。認購一手1000股,中籤率20%。公開資料顯示,晶泰科技於2015年成立,由温書豪、馬健及賴力鵬3名美國麻省理工博士聯合創辦。是一家以智能化、自動化驅動的藥物研發科技公司,為全球生物醫藥企業提供藥物發現一體化解決方案。自成立以來.晶泰科技一直為輝瑞、瓊森、德國達姆施塔特默克集團、中國正大天晴藥業、韓國大熊製藥等眾多全球生物技術與製藥企業集團提供服務,並與之合作。晶泰科技已經建立了一個綜合技術平台,該平台集成了高性能雲計算賦能的計算器式工具,包括基於量子物理的第一性原理計算和人工智能,用於幹實驗室計算和評估,以及機器人自動化的濕實驗室實驗。根據弗若斯特沙利文的資料,晶泰科技是世界上少數幾家領先的基於量子物理、人工智能賦能的藥物及材料科學研發公司之一,在基於量子物理、人工智能賦能的幹實驗室和可擴展、標準化、自動化機器人濕實驗室能力之間建立了一個具有反覆運算反饋迥路的平台。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account